EdgarLookup
8-K XBRL

FORM 8-K

Company
Coeptis Therapeutics Holdings, Inc.
Filed
June 6, 2023
Period of Report
June 5, 2023
Accession Number
0001683168-23-003924

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →